Lexington, MA, United States of America

Ning Li

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Li. Retrieved from https://idiyas.com/inventor/ning-li-77nllun4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ning Li - Innovator in Pharmaceutical Development

Introduction

Ning Li is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs targeting specific receptors. Her innovative work has the potential to impact the treatment of various diseases.

Latest Patents

Ning Li holds a patent for an EP2 antagonist. This drug contains, as an active ingredient, a compound that exhibits antagonistic activity against an EP receptor. It is designed for the prevention and/or treatment of diseases associated with the activation of the EP receptor. The patent outlines a specific formula, wherein all symbols have the same meanings as described in the specification, or a pharmaceutically acceptable salt thereof. She has 1 patent to her name.

Career Highlights

Ning Li is currently employed at Ono Pharmaceutical Co., Ltd. Her work at this esteemed company has allowed her to focus on groundbreaking research and development in the pharmaceutical industry.

Collaborations

Ning Li has collaborated with notable colleagues, including Akio Watanabe and Atsushi Yoshida. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ning Li is a dedicated inventor whose work in pharmaceutical development is paving the way for new treatment options. Her contributions, particularly in the area of EP2 antagonists, highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…